Skip to main content
. 2015 Nov 9;61(Suppl 5):S578–S585. doi: 10.1093/cid/civ513

Figure 3.

Figure 3.

Predicted probability of short-term tetanus immunity (≥0.1 IU/mL) (A) and long-term tetanus immunity (≥1.0 IU/mL) (B) based on the adjusted logistic regression model by age group and sex before and after a Meningococcal A Polysaccharide–Tetanus Toxoid Protein Conjugate Vaccine mass vaccination campaign.